Novo Nordisk Ends Hims & Hers Deal Over Wegovy Copycats, Triggering 28% Stock Drop
In a sharp turn of events for the booming weight-loss drug market, Novo Nordisk has terminated its partnership with Hims & Hers Health Inc., citing the company’s involvement in distributing compounded versions of its blockbuster GLP-1 drug, Wegovy. The news sent HIMS stock tumbling more than 28% in a single trading day, raising serious questions […]
Novo Nordisk Ends Hims & Hers Deal Over Wegovy Copycats, Triggering 28% Stock Drop Read More »